[
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "< 1 μM",
        "unit": "μM",
        "raw_mentions": "In some embodiments, an antibody that binds to a Siglec-8 (e.g. , an antibody that binds to human Siglec-8) has a dissociation constant (Kd) of &lt; Ι μΜ, &lt; 100 nM, &lt; 10 nM, &lt; 2 nM, &lt; 1 nM, &lt; 0.7 nM, &lt;0 .6 nM, ≤ 0.5 nM,≤ 0.1 nM,≤ 0.01 nM, or≤ 0.001 nM (e.g. 10<sup>~8</sup> M or less, e.g. from 10<sup>~8</sup> M to 10<sup>~13</sup> M, e.g., from 10<sup>\"9</sup> M to 10<sup>~13</sup> M). \nIn some embodiments, binding of an anti-Siglec-8 antibody described herein (e.g. , an antibody that binds to human Siglec-8) to an unrelated non-Siglec-8 polypeptide is less than about 10% of the antibody binding to Siglec-8 as measured by methods known in the art (e.g. , enzyme-linked immunosorbent assay (ELISA))."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "< 100 nM",
        "unit": "nM",
        "raw_mentions": "In some embodiments, an antibody that binds to a Siglec-8 (e.g. , an antibody that binds to human Siglec-8) has a dissociation constant (Kd) of &lt; Ι μΜ, &lt; 100 nM, &lt; 10 nM, &lt; 2 nM, &lt; 1 nM, &lt; 0.7 nM, &lt;0 .6 nM, ≤ 0.5 nM,≤ 0.1 nM,≤ 0.01 nM, or≤ 0.001 nM (e.g. 10<sup>~8</sup> M or less, e.g. from 10<sup>~8</sup> M to 10<sup>~13</sup> M, e.g., from 10<sup>\"9</sup> M to 10<sup>~13</sup> M). \nIn some embodiments, binding of an anti-Siglec-8 antibody described herein (e.g. , an antibody that binds to human Siglec-8) to an unrelated non-Siglec-8 polypeptide is less than about 10% of the antibody binding to Siglec-8 as measured by methods known in the art (e.g. , enzyme-linked immunosorbent assay (ELISA))."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "< 10 nM",
        "unit": "nM",
        "raw_mentions": "In some embodiments, an antibody that binds to a Siglec-8 (e.g. , an antibody that binds to human Siglec-8) has a dissociation constant (Kd) of &lt; Ι μΜ, &lt; 100 nM, &lt; 10 nM, &lt; 2 nM, &lt; 1 nM, &lt; 0.7 nM, &lt;0 .6 nM, ≤ 0.5 nM,≤ 0.1 nM,≤ 0.01 nM, or≤ 0.001 nM (e.g. 10<sup>~8</sup> M or less, e.g. from 10<sup>~8</sup> M to 10<sup>~13</sup> M, e.g., from 10<sup>\"9</sup> M to 10<sup>~13</sup> M). \nIn some embodiments, binding of an anti-Siglec-8 antibody described herein (e.g. , an antibody that binds to human Siglec-8) to an unrelated non-Siglec-8 polypeptide is less than about 10% of the antibody binding to Siglec-8 as measured by methods known in the art (e.g. , enzyme-linked immunosorbent assay (ELISA))."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "< 2 nM",
        "unit": "nM",
        "raw_mentions": "In some embodiments, an antibody that binds to a Siglec-8 (e.g. , an antibody that binds to human Siglec-8) has a dissociation constant (Kd) of &lt; Ι μΜ, &lt; 100 nM, &lt; 10 nM, &lt; 2 nM, &lt; 1 nM, &lt; 0.7 nM, &lt;0 .6 nM, ≤ 0.5 nM,≤ 0.1 nM,≤ 0.01 nM, or≤ 0.001 nM (e.g. 10<sup>~8</sup> M or less, e.g. from 10<sup>~8</sup> M to 10<sup>~13</sup> M, e.g., from 10<sup>\"9</sup> M to 10<sup>~13</sup> M). \nIn some embodiments, binding of an anti-Siglec-8 antibody described herein (e.g. , an antibody that binds to human Siglec-8) to an unrelated non-Siglec-8 polypeptide is less than about 10% of the antibody binding to Siglec-8 as measured by methods known in the art (e.g. , enzyme-linked immunosorbent assay (ELISA))."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "< 1 nM",
        "unit": "nM",
        "raw_mentions": "In some embodiments, an antibody that binds to a Siglec-8 (e.g. , an antibody that binds to human Siglec-8) has a dissociation constant (Kd) of &lt; Ι μΜ, &lt; 100 nM, &lt; 10 nM, &lt; 2 nM, &lt; 1 nM, &lt; 0.7 nM, &lt;0 .6 nM, ≤ 0.5 nM,≤ 0.1 nM,≤ 0.01 nM, or≤ 0.001 nM (e.g. 10<sup>~8</sup> M or less, e.g. from 10<sup>~8</sup> M to 10<sup>~13</sup> M, e.g., from 10<sup>\"9</sup> M to 10<sup>~13</sup> M). \nIn some embodiments, binding of an anti-Siglec-8 antibody described herein (e.g. , an antibody that binds to human Siglec-8) to an unrelated non-Siglec-8 polypeptide is less than about 10% of the antibody binding to Siglec-8 as measured by methods known in the art (e.g. , enzyme-linked immunosorbent assay (ELISA))."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "< 0.7 nM",
        "unit": "nM",
        "raw_mentions": "In some embodiments, an antibody that binds to a Siglec-8 (e.g. , an antibody that binds to human Siglec-8) has a dissociation constant (Kd) of &lt; Ι μΜ, &lt; 100 nM, &lt; 10 nM, &lt; 2 nM, &lt; 1 nM, &lt; 0.7 nM, &lt;0 .6 nM, ≤ 0.5 nM,≤ 0.1 nM,≤ 0.01 nM, or≤ 0.001 nM (e.g. 10<sup>~8</sup> M or less, e.g. from 10<sup>~8</sup> M to 10<sup>~13</sup> M, e.g., from 10<sup>\"9</sup> M to 10<sup>~13</sup> M). \nIn some embodiments, binding of an anti-Siglec-8 antibody described herein (e.g. , an antibody that binds to human Siglec-8) to an unrelated non-Siglec-8 polypeptide is less than about 10% of the antibody binding to Siglec-8 as measured by methods known in the art (e.g. , enzyme-linked immunosorbent assay (ELISA))."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "< 0.6 nM",
        "unit": "nM",
        "raw_mentions": "In some embodiments, an antibody that binds to a Siglec-8 (e.g. , an antibody that binds to human Siglec-8) has a dissociation constant (Kd) of &lt; Ι μΜ, &lt; 100 nM, &lt; 10 nM, &lt; 2 nM, &lt; 1 nM, &lt; 0.7 nM, &lt;0 .6 nM, ≤ 0.5 nM,≤ 0.1 nM,≤ 0.01 nM, or≤ 0.001 nM (e.g. 10<sup>~8</sup> M or less, e.g. from 10<sup>~8</sup> M to 10<sup>~13</sup> M, e.g., from 10<sup>\"9</sup> M to 10<sup>~13</sup> M). \nIn some embodiments, binding of an anti-Siglec-8 antibody described herein (e.g. , an antibody that binds to human Siglec-8) to an unrelated non-Siglec-8 polypeptide is less than about 10% of the antibody binding to Siglec-8 as measured by methods known in the art (e.g. , enzyme-linked immunosorbent assay (ELISA))."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "≤ 0.5 nM",
        "unit": "nM",
        "raw_mentions": "In some embodiments, an antibody that binds to a Siglec-8 (e.g. , an antibody that binds to human Siglec-8) has a dissociation constant (Kd) of &lt; Ι μΜ, &lt; 100 nM, &lt; 10 nM, &lt; 2 nM, &lt; 1 nM, &lt; 0.7 nM, &lt;0 .6 nM, ≤ 0.5 nM,≤ 0.1 nM,≤ 0.01 nM, or≤ 0.001 nM (e.g. 10<sup>~8</sup> M or less, e.g. from 10<sup>~8</sup> M to 10<sup>~13</sup> M, e.g., from 10<sup>\"9</sup> M to 10<sup>~13</sup> M). \nIn some embodiments, binding of an anti-Siglec-8 antibody described herein (e.g. , an antibody that binds to human Siglec-8) to an unrelated non-Siglec-8 polypeptide is less than about 10% of the antibody binding to Siglec-8 as measured by methods known in the art (e.g. , enzyme-linked immunosorbent assay (ELISA))."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "≤ 0.1 nM",
        "unit": "nM",
        "raw_mentions": "In some embodiments, an antibody that binds to a Siglec-8 (e.g. , an antibody that binds to human Siglec-8) has a dissociation constant (Kd) of &lt; Ι μΜ, &lt; 100 nM, &lt; 10 nM, &lt; 2 nM, &lt; 1 nM, &lt; 0.7 nM, &lt;0 .6 nM, ≤ 0.5 nM,≤ 0.1 nM,≤ 0.01 nM, or≤ 0.001 nM (e.g. 10<sup>~8</sup> M or less, e.g. from 10<sup>~8</sup> M to 10<sup>~13</sup> M, e.g., from 10<sup>\"9</sup> M to 10<sup>~13</sup> M). \nIn some embodiments, binding of an anti-Siglec-8 antibody described herein (e.g. , an antibody that binds to human Siglec-8) to an unrelated non-Siglec-8 polypeptide is less than about 10% of the antibody binding to Siglec-8 as measured by methods known in the art (e.g. , enzyme-linked immunosorbent assay (ELISA))."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "≤ 0.01 nM",
        "unit": "nM",
        "raw_mentions": "In some embodiments, an antibody that binds to a Siglec-8 (e.g. , an antibody that binds to human Siglec-8) has a dissociation constant (Kd) of &lt; Ι μΜ, &lt; 100 nM, &lt; 10 nM, &lt; 2 nM, &lt; 1 nM, &lt; 0.7 nM, &lt;0 .6 nM, ≤ 0.5 nM,≤ 0.1 nM,≤ 0.01 nM, or≤ 0.001 nM (e.g. 10<sup>~8</sup> M or less, e.g. from 10<sup>~8</sup> M to 10<sup>~13</sup> M, e.g., from 10<sup>\"9</sup> M to 10<sup>~13</sup> M). \nIn some embodiments, binding of an anti-Siglec-8 antibody described herein (e.g. , an antibody that binds to human Siglec-8) to an unrelated non-Siglec-8 polypeptide is less than about 10% of the antibody binding to Siglec-8 as measured by methods known in the art (e.g. , enzyme-linked immunosorbent assay (ELISA))."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "≤ 0.001 nM",
        "unit": "nM",
        "raw_mentions": "In some embodiments, an antibody that binds to a Siglec-8 (e.g. , an antibody that binds to human Siglec-8) has a dissociation constant (Kd) of &lt; Ι μΜ, &lt; 100 nM, &lt; 10 nM, &lt; 2 nM, &lt; 1 nM, &lt; 0.7 nM, &lt;0 .6 nM, ≤ 0.5 nM,≤ 0.1 nM,≤ 0.01 nM, or≤ 0.001 nM (e.g. 10<sup>~8</sup> M or less, e.g. from 10<sup>~8</sup> M to 10<sup>~13</sup> M, e.g., from 10<sup>\"9</sup> M to 10<sup>~13</sup> M). \nIn some embodiments, binding of an anti-Siglec-8 antibody described herein (e.g. , an antibody that binds to human Siglec-8) to an unrelated non-Siglec-8 polypeptide is less than about 10% of the antibody binding to Siglec-8 as measured by methods known in the art (e.g. , enzyme-linked immunosorbent assay (ELISA))."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "< 1",
        "unit": "μM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In certain embodiments, an anti-Siglec-8 antibody provided herein has a dissociation constant (Kd) of < 1μM, < 150 nM, < 100 nM, < 50 nM, < 10 nM, < 1 nM, ≤ 0.1 nM, ≤ 0.01 nM, or ≤ 0.001 nM (e.g. 10-8 M or less, e.g. from 10-8 M to 10-13 M, e.g., from 10-9 M to 10-13 M).\n* In one embodiment, the binding affinity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore™-2000 or a BIAcore™-3000 (BIAcore, Inc., Piscataway, N.J.) at 25° C with immobilized antigen CM5 chips at -10 response units (RU), and the equilibrium dissociation constant (Kd) is calculated as the ratio koff/kon.\n* In another embodiment, biolayer interferometry may be used to determine the affinity of anti-Siglec-8 antibodies against Siglec-8, and the binding affinity can be measured using an instrument such as, for example, the Octet Red 384 System (ForteBio), and the affinity measurements can be obtained by incubating Siglec-8-Fc tagged protein with increasing concentrations of mouse, chimeric, or humanized anti-Siglec-8 Fab fragments.\n* In some embodiments, the binding avidity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore T100, and dimeric Siglec-8 is diluted in assay buffer at various concentrations, for example, at a concentration ranging from 15nM to 1.88pM."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "< 150",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In certain embodiments, an anti-Siglec-8 antibody provided herein has a dissociation constant (Kd) of < 1μM, < 150 nM, < 100 nM, < 50 nM, < 10 nM, < 1 nM, ≤ 0.1 nM, ≤ 0.01 nM, or ≤ 0.001 nM (e.g. 10-8 M or less, e.g. from 10-8 M to 10-13 M, e.g., from 10-9 M to 10-13 M).\n* In one embodiment, the binding affinity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore™-2000 or a BIAcore™-3000 (BIAcore, Inc., Piscataway, N.J.) at 25° C with immobilized antigen CM5 chips at -10 response units (RU), and the equilibrium dissociation constant (Kd) is calculated as the ratio koff/kon.\n* In another embodiment, biolayer interferometry may be used to determine the affinity of anti-Siglec-8 antibodies against Siglec-8, and the binding affinity can be measured using an instrument such as, for example, the Octet Red 384 System (ForteBio), and the affinity measurements can be obtained by incubating Siglec-8-Fc tagged protein with increasing concentrations of mouse, chimeric, or humanized anti-Siglec-8 Fab fragments.\n* In some embodiments, the binding avidity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore T100, and dimeric Siglec-8 is diluted in assay buffer at various concentrations, for example, at a concentration ranging from 15nM to 1.88pM."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "< 100",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In certain embodiments, an anti-Siglec-8 antibody provided herein has a dissociation constant (Kd) of < 1μM, < 150 nM, < 100 nM, < 50 nM, < 10 nM, < 1 nM, ≤ 0.1 nM, ≤ 0.01 nM, or ≤ 0.001 nM (e.g. 10-8 M or less, e.g. from 10-8 M to 10-13 M, e.g., from 10-9 M to 10-13 M).\n* In one embodiment, the binding affinity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore™-2000 or a BIAcore™-3000 (BIAcore, Inc., Piscataway, N.J.) at 25° C with immobilized antigen CM5 chips at -10 response units (RU), and the equilibrium dissociation constant (Kd) is calculated as the ratio koff/kon.\n* In another embodiment, biolayer interferometry may be used to determine the affinity of anti-Siglec-8 antibodies against Siglec-8, and the binding affinity can be measured using an instrument such as, for example, the Octet Red 384 System (ForteBio), and the affinity measurements can be obtained by incubating Siglec-8-Fc tagged protein with increasing concentrations of mouse, chimeric, or humanized anti-Siglec-8 Fab fragments.\n* In some embodiments, the binding avidity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore T100, and dimeric Siglec-8 is diluted in assay buffer at various concentrations, for example, at a concentration ranging from 15nM to 1.88pM."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "< 50",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In certain embodiments, an anti-Siglec-8 antibody provided herein has a dissociation constant (Kd) of < 1μM, < 150 nM, < 100 nM, < 50 nM, < 10 nM, < 1 nM, ≤ 0.1 nM, ≤ 0.01 nM, or ≤ 0.001 nM (e.g. 10-8 M or less, e.g. from 10-8 M to 10-13 M, e.g., from 10-9 M to 10-13 M).\n* In one embodiment, the binding affinity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore™-2000 or a BIAcore™-3000 (BIAcore, Inc., Piscataway, N.J.) at 25° C with immobilized antigen CM5 chips at -10 response units (RU), and the equilibrium dissociation constant (Kd) is calculated as the ratio koff/kon.\n* In another embodiment, biolayer interferometry may be used to determine the affinity of anti-Siglec-8 antibodies against Siglec-8, and the binding affinity can be measured using an instrument such as, for example, the Octet Red 384 System (ForteBio), and the affinity measurements can be obtained by incubating Siglec-8-Fc tagged protein with increasing concentrations of mouse, chimeric, or humanized anti-Siglec-8 Fab fragments.\n* In some embodiments, the binding avidity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore T100, and dimeric Siglec-8 is diluted in assay buffer at various concentrations, for example, at a concentration ranging from 15nM to 1.88pM."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "< 10",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In certain embodiments, an anti-Siglec-8 antibody provided herein has a dissociation constant (Kd) of < 1μM, < 150 nM, < 100 nM, < 50 nM, < 10 nM, < 1 nM, ≤ 0.1 nM, ≤ 0.01 nM, or ≤ 0.001 nM (e.g. 10-8 M or less, e.g. from 10-8 M to 10-13 M, e.g., from 10-9 M to 10-13 M).\n* In one embodiment, the binding affinity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore™-2000 or a BIAcore™-3000 (BIAcore, Inc., Piscataway, N.J.) at 25° C with immobilized antigen CM5 chips at -10 response units (RU), and the equilibrium dissociation constant (Kd) is calculated as the ratio koff/kon.\n* In another embodiment, biolayer interferometry may be used to determine the affinity of anti-Siglec-8 antibodies against Siglec-8, and the binding affinity can be measured using an instrument such as, for example, the Octet Red 384 System (ForteBio), and the affinity measurements can be obtained by incubating Siglec-8-Fc tagged protein with increasing concentrations of mouse, chimeric, or humanized anti-Siglec-8 Fab fragments.\n* In some embodiments, the binding avidity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore T100, and dimeric Siglec-8 is diluted in assay buffer at various concentrations, for example, at a concentration ranging from 15nM to 1.88pM."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "< 1",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In certain embodiments, an anti-Siglec-8 antibody provided herein has a dissociation constant (Kd) of < 1μM, < 150 nM, < 100 nM, < 50 nM, < 10 nM, < 1 nM, ≤ 0.1 nM, ≤ 0.01 nM, or ≤ 0.001 nM (e.g. 10-8 M or less, e.g. from 10-8 M to 10-13 M, e.g., from 10-9 M to 10-13 M).\n* In one embodiment, the binding affinity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore™-2000 or a BIAcore™-3000 (BIAcore, Inc., Piscataway, N.J.) at 25° C with immobilized antigen CM5 chips at -10 response units (RU), and the equilibrium dissociation constant (Kd) is calculated as the ratio koff/kon.\n* In another embodiment, biolayer interferometry may be used to determine the affinity of anti-Siglec-8 antibodies against Siglec-8, and the binding affinity can be measured using an instrument such as, for example, the Octet Red 384 System (ForteBio), and the affinity measurements can be obtained by incubating Siglec-8-Fc tagged protein with increasing concentrations of mouse, chimeric, or humanized anti-Siglec-8 Fab fragments.\n* In some embodiments, the binding avidity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore T100, and dimeric Siglec-8 is diluted in assay buffer at various concentrations, for example, at a concentration ranging from 15nM to 1.88pM."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "≤ 0.1",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In certain embodiments, an anti-Siglec-8 antibody provided herein has a dissociation constant (Kd) of < 1μM, < 150 nM, < 100 nM, < 50 nM, < 10 nM, < 1 nM, ≤ 0.1 nM, ≤ 0.01 nM, or ≤ 0.001 nM (e.g. 10-8 M or less, e.g. from 10-8 M to 10-13 M, e.g., from 10-9 M to 10-13 M).\n* In one embodiment, the binding affinity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore™-2000 or a BIAcore™-3000 (BIAcore, Inc., Piscataway, N.J.) at 25° C with immobilized antigen CM5 chips at -10 response units (RU), and the equilibrium dissociation constant (Kd) is calculated as the ratio koff/kon.\n* In another embodiment, biolayer interferometry may be used to determine the affinity of anti-Siglec-8 antibodies against Siglec-8, and the binding affinity can be measured using an instrument such as, for example, the Octet Red 384 System (ForteBio), and the affinity measurements can be obtained by incubating Siglec-8-Fc tagged protein with increasing concentrations of mouse, chimeric, or humanized anti-Siglec-8 Fab fragments.\n* In some embodiments, the binding avidity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore T100, and dimeric Siglec-8 is diluted in assay buffer at various concentrations, for example, at a concentration ranging from 15nM to 1.88pM."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "≤ 0.01",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In certain embodiments, an anti-Siglec-8 antibody provided herein has a dissociation constant (Kd) of < 1μM, < 150 nM, < 100 nM, < 50 nM, < 10 nM, < 1 nM, ≤ 0.1 nM, ≤ 0.01 nM, or ≤ 0.001 nM (e.g. 10-8 M or less, e.g. from 10-8 M to 10-13 M, e.g., from 10-9 M to 10-13 M).\n* In one embodiment, the binding affinity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore™-2000 or a BIAcore™-3000 (BIAcore, Inc., Piscataway, N.J.) at 25° C with immobilized antigen CM5 chips at -10 response units (RU), and the equilibrium dissociation constant (Kd) is calculated as the ratio koff/kon.\n* In another embodiment, biolayer interferometry may be used to determine the affinity of anti-Siglec-8 antibodies against Siglec-8, and the binding affinity can be measured using an instrument such as, for example, the Octet Red 384 System (ForteBio), and the affinity measurements can be obtained by incubating Siglec-8-Fc tagged protein with increasing concentrations of mouse, chimeric, or humanized anti-Siglec-8 Fab fragments.\n* In some embodiments, the binding avidity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore T100, and dimeric Siglec-8 is diluted in assay buffer at various concentrations, for example, at a concentration ranging from 15nM to 1.88pM."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "≤ 0.001",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In certain embodiments, an anti-Siglec-8 antibody provided herein has a dissociation constant (Kd) of < 1μM, < 150 nM, < 100 nM, < 50 nM, < 10 nM, < 1 nM, ≤ 0.1 nM, ≤ 0.01 nM, or ≤ 0.001 nM (e.g. 10-8 M or less, e.g. from 10-8 M to 10-13 M, e.g., from 10-9 M to 10-13 M).\n* In one embodiment, the binding affinity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore™-2000 or a BIAcore™-3000 (BIAcore, Inc., Piscataway, N.J.) at 25° C with immobilized antigen CM5 chips at -10 response units (RU), and the equilibrium dissociation constant (Kd) is calculated as the ratio koff/kon.\n* In another embodiment, biolayer interferometry may be used to determine the affinity of anti-Siglec-8 antibodies against Siglec-8, and the binding affinity can be measured using an instrument such as, for example, the Octet Red 384 System (ForteBio), and the affinity measurements can be obtained by incubating Siglec-8-Fc tagged protein with increasing concentrations of mouse, chimeric, or humanized anti-Siglec-8 Fab fragments.\n* In some embodiments, the binding avidity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore T100, and dimeric Siglec-8 is diluted in assay buffer at various concentrations, for example, at a concentration ranging from 15nM to 1.88pM."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "10-8",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In certain embodiments, an anti-Siglec-8 antibody provided herein has a dissociation constant (Kd) of < 1μM, < 150 nM, < 100 nM, < 50 nM, < 10 nM, < 1 nM, ≤ 0.1 nM, ≤ 0.01 nM, or ≤ 0.001 nM (e.g. 10-8 M or less, e.g. from 10-8 M to 10-13 M, e.g., from 10-9 M to 10-13 M).\n* In one embodiment, the binding affinity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore™-2000 or a BIAcore™-3000 (BIAcore, Inc., Piscataway, N.J.) at 25° C with immobilized antigen CM5 chips at -10 response units (RU), and the equilibrium dissociation constant (Kd) is calculated as the ratio koff/kon.\n* In another embodiment, biolayer interferometry may be used to determine the affinity of anti-Siglec-8 antibodies against Siglec-8, and the binding affinity can be measured using an instrument such as, for example, the Octet Red 384 System (ForteBio), and the affinity measurements can be obtained by incubating Siglec-8-Fc tagged protein with increasing concentrations of mouse, chimeric, or humanized anti-Siglec-8 Fab fragments.\n* In some embodiments, the binding avidity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore T100, and dimeric Siglec-8 is diluted in assay buffer at various concentrations, for example, at a concentration ranging from 15nM to 1.88pM."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "10-9",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In certain embodiments, an anti-Siglec-8 antibody provided herein has a dissociation constant (Kd) of < 1μM, < 150 nM, < 100 nM, < 50 nM, < 10 nM, < 1 nM, ≤ 0.1 nM, ≤ 0.01 nM, or ≤ 0.001 nM (e.g. 10-8 M or less, e.g. from 10-8 M to 10-13 M, e.g., from 10-9 M to 10-13 M).\n* In one embodiment, the binding affinity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore™-2000 or a BIAcore™-3000 (BIAcore, Inc., Piscataway, N.J.) at 25° C with immobilized antigen CM5 chips at -10 response units (RU), and the equilibrium dissociation constant (Kd) is calculated as the ratio koff/kon.\n* In another embodiment, biolayer interferometry may be used to determine the affinity of anti-Siglec-8 antibodies against Siglec-8, and the binding affinity can be measured using an instrument such as, for example, the Octet Red 384 System (ForteBio), and the affinity measurements can be obtained by incubating Siglec-8-Fc tagged protein with increasing concentrations of mouse, chimeric, or humanized anti-Siglec-8 Fab fragments.\n* In some embodiments, the binding avidity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore T100, and dimeric Siglec-8 is diluted in assay buffer at various concentrations, for example, at a concentration ranging from 15nM to 1.88pM."
    },
    {
        "molecule_name": "anti-Siglec-8 antibody",
        "protein_target_name": "Siglec-8",
        "binding_metric": "Kd",
        "value": "10-13",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In certain embodiments, an anti-Siglec-8 antibody provided herein has a dissociation constant (Kd) of < 1μM, < 150 nM, < 100 nM, < 50 nM, < 10 nM, < 1 nM, ≤ 0.1 nM, ≤ 0.01 nM, or ≤ 0.001 nM (e.g. 10-8 M or less, e.g. from 10-8 M to 10-13 M, e.g., from 10-9 M to 10-13 M).\n* In one embodiment, the binding affinity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore™-2000 or a BIAcore™-3000 (BIAcore, Inc., Piscataway, N.J.) at 25° C with immobilized antigen CM5 chips at -10 response units (RU), and the equilibrium dissociation constant (Kd) is calculated as the ratio koff/kon.\n* In another embodiment, biolayer interferometry may be used to determine the affinity of anti-Siglec-8 antibodies against Siglec-8, and the binding affinity can be measured using an instrument such as, for example, the Octet Red 384 System (ForteBio), and the affinity measurements can be obtained by incubating Siglec-8-Fc tagged protein with increasing concentrations of mouse, chimeric, or humanized anti-Siglec-8 Fab fragments.\n* In some embodiments, the binding avidity of the anti-Siglec-8 antibody can be determined by a surface plasmon resonance assay, and the Kd or Kd value can be measured by using a BIAcore T100, and dimeric Siglec-8 is diluted in assay buffer at various concentrations, for example, at a concentration ranging from 15nM to 1.88pM."
    }
]